eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
3/2010
vol. 7
 
Share:
Send email
Share:
abstract:

Optimal medical treatment and health-related quality of life in patients with chronic systolic heart failure. 3-year follow-up

Bożena Szyguła-Jurkiewicz
,
Aleksander Owczarek
,
Romuald Wojnicz
,
Robert Pudlo
,
Barbara Schmidt
,
Magdalena Fryś-Kubala
,
Karolina Klimaszewska
,
Marian Zembala
,
Lech Poloński

Kardiochirurgia i Torakochirurgia Polska 2010; 7 (3): 331–337
Online publish date: 2010/10/01
View full text Get citation
 
Background: Despite considerable progress in the pharmacological and interventional treatment of chronic heart failure (HF) it still constitutes a significant clinical problem.

Aim: The aim of the work was to evaluate HRQoL in patients with HF and optimal medical therapy during 3 years of follow-up.

Material and methods: We analysed 197 hospitalised patients with stable systolic HF (NYHA class II and III). Three months prior to hospitalisation the patients were evaluated and received pharmacological recommendations. The therapeutic programme encompassed: maximal tolerated doses of ACEI or ARB, maximal tolerated doses of β-blockers (metoprolol CR or carvedilol), spironolactone, furosemide and digoxin (65% of patients).

Inclusion criteria were: stable systolic HF (LVEDd > 57 mm and LVEF < 40%) lasting a minimum of 6 months. Exclusion criteria were: coronary artery stenosis (vascular lumen > 30%) in coronarography, planned heart transplantation and lack of written consent for inclusion into the study. Clinical observation commenced on admission to hospital and lasted 3 years.

Results: Men constituted 82.7%. There were 157 patients (77.7%) in NYHA class II, and 40 (20%) in class III. 130 (66%) patients suffered from arterial hypertension. In the 3-year observation period 18.4% of patients died, urgent transplantation was necessary in 3.1%, whilst hospitalisation in 30.1% of patients. In this period we observed a significant improvement within all indexes of HRQoL.

Conclusions: Optimal pharmacological treatment and the patients’ co-operation in the therapeutic process brought a significant improvement within HRQoL. The biggest improvement was noted with reference to the RP index (role limitation due to physical health) and MH (mental health).
keywords:

health-related quality of life, heart failure
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.